Shigella infections in children: New insights

Seminars in Pediatric Infectious Diseases

Volumn 15, Issue 4, 2004, Pages 246-252

  Ashkenazi, Shai ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; BACTERIAL TOXIN; CEFACLOR; CEFALEXIN; CEFAMANDOLE; CEFIXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SHIGELLA VACCINE; VIRULENCE FACTOR;

ABDOMINAL ABSCESS; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ANTIMICROBIAL THERAPY; APPENDICITIS; BACTEREMIA; BACTERIAL VIRULENCE; BRAIN DISEASE; CHILD; CLINICAL FEATURE; COLON PERFORATION; COMA; DISORIENTATION; DRUG EFFICACY; DRUG SAFETY; FECES CULTURE; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; INTESTINE EPITHELIUM CELL; INTESTINE OBSTRUCTION; JOINT INJURY; LETHARGY; LEUKOCYTE; MACROPHAGE; NEUROLOGIC DISEASE; NEWBORN INFECTION; NUTRITIONAL SUPPORT; PATHOGENICITY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; REVIEW; SEIZURE; SHIGELLA; SHIGELLOSIS; URINARY TRACT INFECTION; VAGINA DISCHARGE; VULVOVAGINITIS;

EID: 5644254821     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.spid.2004.07.005     Document Type: Article

References (84)

1. P.O. Ozuah Shigella update Pediatr Rev 19 1998 100
2. B.H. Edwards Salmonella and Shigella species Clin Lab Med 19 1999 469 487
3. Y. Finkelstein, O. Moran, Y. Avitzur Clinical dysentery in hospitalized children Infection 30 2002 132 135
4. V. Prado, R. Lagos, J.P. Nataro Population-based study of the incidence of Shigella diarrhea and causative serotypes in Santiago, Chile Pediatr Infect Dis J 18 1999 500 505
5. S. Ashkenazi, I. Levy, V. Kazaronovski Growing antimicrobial resistance of Shigella isolates J Antimicrob Chemother 51 2003 427 429
6. S. Ashkenazi, M. May-Zahav, G. Dinari Recent trends in the epidemiology of Shigella species in Israel Clin Infect Dis 17 1993 897 899
7. Centers for Disease Control and Prevention Summaries of notifiable diseases, United States MMWR 50 2001 1 62
8. K. Yurdakok, N. Sahin, E. Ozmert Shigella gastroenteritis clinical and epidemiological aspects, and antibiotic susceptibility Acta Paediatr Jpn 39 1997 681 684
9. K.L. Kotloff, J.P. Winickoff, B. Ivanoff Global burden of Shigella infections implications for vaccine development and implementation of control strategies Bull World Health Organ 77 1999 651 666
10. S. Ashkenazi Shigella species V.L. Yu R. Weber D. Raoult (ed 2) Antimicrobial therapy and vaccines vol 1 2002 Apple Tree Production New York 615 621
11. P.J.P. Sansonetti Rupture, invasion and inflammatory destruction of intestinal barrier by Shigella, making sense of prokaryote-eukaryote cross-talks Microbiol Rev 25 2001 3 14
12. R. Raqib, B. Wretlind, J. Andersson Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma J Infect Dis 171 1995 376 384
13. A. Zychlinsky, K. Thirumalai, J. Arondel In vivo apoptosis in Shigella flexneri infections Infect Immun 64 1996 5357 5365
14. S.S. Way, A.C. Borczuk, R. Dominitz An essential role for gamma interferon in innate resistance to Shigella flexneri infection Infect Immun 66 1998 1342 1380
15. M.I. Fernandez, P.J. Sansonetti Shigella interaction with intestinal epithelial cells determines the innate immune response in shigellosis Int J Med Microbiol 293 2003 55 5567
16. C. Buchrieser, P. Glaser, C. Rusniok The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri Mol Microbiol 38 2000 760 771
17. J.E. Galan, A. Collmer Type III secretion machines bacterial devices for protein delivery into host cells Science 284 1999 1322 1328
18. M. Ingersoll, E.A. Groisman, A. Zychlinsky Pathogenicity islands of Shigella Curr Top Microbiol Immunol 264 2002 49 65
19. C. Sasakawa, K. Kamata, T. Sakai Virulence-associated genetic regions comprising 31 kilobases of the 230-kilobase plasmid in Shigella flexneri 2a J Bacteriol 170 1988 2480 2484
20. A.T. Maurelli, B. Baudry, H. d'Hauteville Cloning of plasmid DNA sequences involved in invasion of HeLa cells by Shigella flexneri Infect Immun 49 1984 164 171
21. A. Blocker, P. Gounon, E. Larquet The tripartite type III secretion of Shigella flexneri inserts IpaB and IpaC into host membranes J Cell Biol 147 1999 683 693
22. A.L. Page, H. Ohayon, P.J. Sansonetti The secreted IpaB and IpaC invasions and their cytoplasmic chaperone IpgC invasins and their cytoplasmic chaperone IpgC are required for intercellular dissemination of Shigella flexneri Cell Microbiol 1 1999 183 193
23. M.L. Bernardini, J. Mounier, H. d'Hauteville Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin Proc Natl Acad Sci USA 86 1989 3867 3871
24. M.B. Goldberg, J.A. Theriot Shigella flexneri surface protein IcsA is sufficient to direct actin-based motility Proc Natl Acad Sci USA 92 1995 6572 6576
25. N. Nakata, C. Sasakawa, N. Okada Identification and characterization of virK, a virulence-associated large plasmid gene essential for intercellular spreading of Shigella flexneri Mol Microbiol 6 1992 2387 2395
26. J. Steinhauer, R. Agha, T. Pham The unipolar Shigella surface protein IcsA is targeted directly to the bacterial old pole IcsP cleavage of IcsA occurs over the entire bacterial surface Mol Microbiol 32 1999 367 377
27. B. Adler, C. Sasakawa, T. Tobe A dual transcriptional activation system for the 230 kb plasmid genes coding for virulence-associated antigens of Shigella flexneri Mol Microbiol 3 1989 627 635
28. A.T. Maurelli, P.J. Sansonetti Identification of a chromosomal gene controlling temperature regulated expression of Shigella virulence Proc Natl AACD Sci USA 85 1988 2820 2824
29. M. Bitzan, D.M. te Loo Interaction of Shiga toxin with endothelial cells Methods Mol Med 73 2003 243 262
30. K. Sandvig Shiga toxins Toxicon 39 2001 1629 1635
31. P.E. Ray, X.H. Liu Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome Pediatr Nephrol 16 2001 823 839
32. A.S. Faruque, T. Teka, G.J. Fuchs Shigellosis in children a clinico-epidemiological comparison between Shigella dysenteriae type I and Shigella flexneri Ann Trop Paediatr 18 1998 197 201
33. M. Vargas, J. Gascon, M.T. Jimenez-De-anta Prevalence of Shigella enterotoxins 1 and 2 among Shigella strains isolated from patients with traveler's diarrhea J Clin Microbiol 37 1999 3608 3611
34. R. Raqib, A.A. Lindberg, B. Wretlind Persistence of local cytokine production in shigellosis in acute and convalescent stages Infect Immun 63 1995 289 296
35. T. Nonaka, T. Kuwabara, H. Mimuro Shigella-induced necrosis and apoptosis of U937 cells and J774 macrophages Microbiology 149 2003 2513 2527
36. T. Adam, M. Arpin, M.C. Prevost Cytoskeletal rearrangements and the functional role of T-plastin during entry of Shigella flexneri into HeLa cells J Cell Biol 129 1995 367 381
37. A. Hall Rho GT. Pases and the actin cytoskeleton Science 279 1998 509 514
38. M.B. Goldberg, O. Barzu, C. Parsot Unipolar localization and ATPase activity of IcsA, a Shigella flexneri protein involved in intracellular movement Infect Agents Dis 2 1993 210 211
39. P.J. Sansonetti, J. Arondel, M. Huerre Interleukin-8 controls bacterial transepithelial translocation at the cost of epithelial destruction in experimental shigellosis Infect Immun 67 1999 1471 1480
40. T. Adam Exploitation of host factors for efficient infection by Shigella Int J Med Microbiol 291 2001 287 298
41. H. Hilbi, J.E. Moss, D. Hersh Shigella-induced apoptosis is dependent on casepase-1 which binds to IpaB J Biol Chem 273 1998 32895 32900
42. E. Cario, D. Brown, M. McKee Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium Am J Pathol 160 2002 1665 1673
43. Z. Zhang, L. Jin, G. Champion Shigella infection in a SCID mouse-human intestinal xenograft model role for neutrophils in containing bacterial dissemination in human intestine Infect Immun 69 2001 3240 3247
44. M.J. Strulens, D. Patte, I. Kabir Shigella septicemia prevalence, presentation, risk factors and outcome J Infect Dis 152 1985 784 790
45. D. Greenberg, S. Marcu, R. Melamed Shigella bacteremia a retrospective study Clin Pediatr (Phila) 42 2003 411 415
46. J.T. Baer, D.J. Vugia, A.L. Reingold HIV infection as a risk factor for shigellosis Emerg Infect Dis 5 1999 820 823
47. J. Huebner, W. Czerwenka, E. Gruner Shigellemia in AIDS patients case report and review of the literature Infection 21 1993 122 124
48. M. Kirstjansson, B. Viner, J.N. Maslow Polymicrobial and recurrent bacteremia with Shigella in a patient with AIDS Scand J Infect Dis 26 1994 411 416
49. D. Miron, I. Sochotnick, D. Yardeni Surgical complications of shigellosis in children Pediatr Infect Dis J 19 2000 898 900
50. W.A. Khan, U. Dhar, M.A. Salam Central nervous manifestations of childhood shigellosis prevalence, risk factors, and outcome Pediatrics 103 1999 E18
51. Z. Perles, J. Bar-Ziv, E. Granot Brain edema an underdiagnosed complication of Shigella infection Pediatr Infect Dis J 14 1995 1114 1115
52. F.B. Plotz, H.G. Arets, A. Fleer Lethal encephalopathy complicating childhood shigellosis Eur J Pediatr 158 1999 550 552
53. A. Goren, S. Freier, J. Passwell Lethal toxic encephalopathy due to childhood shigellosis in a developed country Pediatrics 89 1992 1189 1193
54. Y. Yuhas, L. Shulman, A. Weizman Involvement of tumor necrosis factor alpha and interleukin-1beta in enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae Infect Immun 67 1999 1455 1460
55. J. Balter-Seri, Y. Yuhas, A. Weizman Role of nitric oxide in the enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae Infect Immun 67 1999 6364 6368
56. Y. Yuhas, A. Weizman, S. Ashkenazi Bidirectional concentration-dependent effects of tumor necrosis factor alpha in Shigella dysenteriae-related seizures Infect Immun 71 2003 2288 2291
57. M. Anatoliotaki, E. Galanakis, T. Tsekoura Urinary tract infection caused by Shigella sonnei Scand J Infect Dis 35 2003 431 433
58. M. Baiulescu, P.R. Hannon, J.F. Marcinak, W.M. Janda, P.C. Schreckenberger Chronic vulvovaginitis caused by antibiotic-resistant Shigella flexneri in a prepubertal child Pediatr Infect Dis J 21 2002 170 172
59. Y. Viner, D. Miron, E. Gottfried Neonatal shigellosis Isr Med Assoc J 3 2001 964 966
60. H.F. Gomez, T.J. Ochoa, L.G. Carlin Human lactoferrin impairs virulence of Shigella flexneri J Infect Dis 187 2003 87 95
61. S. Dutta, A. Chatterjee, P. Dutta Sensitivity and performance characteristics of a direct PCR with stool samples in comparison to conventional techniques for diagnosis of Shigella and enteroinvasive Escherichia coli infection in children with acute diarrhoea in Calcutta, India J Med Microbiol 50 2001 667 674
62. K. Kakinuma, M. Fukushima, R. Kawaguchi Detection and identification of Escherichia coli, Shigella, and Salmonella by microarrays using the gyrB gene Biotechnol Bioeng 83 2003 721 726
63. D.D. Szakal, G. Schneider, T. Pal A colony plot immune assay to identify enteroinvasive Escherichia coli and Shigella in stool samples Diagn Microbiol Infect Dis 45 2003 165 171
64. A.M. Khan, G.H. Rabbani, A.S. Faruque WHO-ORS in treatment of shigellosis J Diarrhoeal Dis Res 17 1999 88 89
65. I. Kabir, M.M. Rahman, R. Haider Increased height gain of children fed a high-protein diet during convalescence from shigellosis a six-month follow-up study J Nutr 128 1998 1688 1691
66. S.K. Bhattacharya, D. Sur An evaluation of current shigellosis treatment Expert Opin Pharmacother 4 2003 1315 1320
67. M.L. Replogle, D.W. Fleming, P.R. Cieslak Emergence of antimicrobial-resistant shigellosis in Oregon Clin Infect Dis 30 2000 515 519
68. CDC National Anticmicrobial Resistance Monitoring System. Available at: http://www.cdc.gov/narms/annual/2001/table/0125.htm; Internet; accessed August 11, 2004
69. th Interscience Conference of Antimicrobial Agents and Chemotherapy, New Orleans, Louisiana, Sept. 1996
70. Y.W. Chu, E.T. Houang, D.J. Lyon Antimicrobial resistance in Shigella flexneri and Shigella sonnei in Hong Kong, 1986 to 1995 Antimicrob Agents Chemother 42 1998 440 443
71. S. Maraki, A. Georgiladakis, A. Christidou Antimicrobial susceptibilities and beta-lactamase production of Shigella isolates in Crete, Greece, during the period 1991-1995 APMIS 106 1998 879 883
72. A.A. Lima, N.L. Lima, M.C. Pinho High frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, streptomycin, chloramphenicol, and tetracycline isolated from patients with shigellosis in northeastern Brazil during the period 1988 to 1993 Antimicrob Agents Chemother 39 1995 256 259
73. S.R. Lin, S.F. Chang Drug resistance and plasmid profile of shigellae in Taiwan Epidemiol Infect 108 1992 87 97
74. N. Harnett High level resistance to trimethoprim, cotrimoxazole and other antimicrobial agents among clinical isolates of Shigella species in Ontario, Canada--an update Epidemiol Infect 109 1992 463 472
75. A.F. Kagalwalla, S.N. Khan, Y.A. Kagalwalla Childhood shigellosis in Saudi Arabia Pediatr Infect Dis J 11 1992 215 219
76. U. Thisyakorn, S. Rienprayoon Shigellosis in Thai children epidemiologic, clinical and laboratory features Pediatr Infect Dis J 11 1992 213 215
77. M.A. Salam, U. Dhar, W.A. Khan Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis Lancet 352 1998 522 527
78. The Dysentery Study Group Multicenter, randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children Pediatr Infect Dis J 21 2002 1136 1141
79. K. Sarkar, S. Ghosh, S.K. Niyogi Shigella dysenteriae type 1 with reduced susceptibility to fluoroquinolones Lancet 361 2003 785
80. A.S. Ghosh, J. Ahamed, K.K. Chauhan Involvement of an efflux system in high-level fluoroquinolone resistance of Shigella dysenteriae Biochem Biophys Res Commun 242 1998 54 56
81. T. Eidlitz-Marcus, Y.H. Cohen, M. Nussinovitch Comparative efficacy of two- and five-day courses of ceftriaxone for treatment of severe shigellosis in children J Pediatr 123 1993 822 824
82. S. Ashkenazi, J. Amir, Y. Waisman A randomized, double-blind study comparing cefixime and trimethoprim-sulfamethoxazole in the treatment of childhood shigellosis J Pediatr 123 1993 817 821
83. Z.C. Acikgoz, Z. Gulay, M. Bicmen CTX-M-3 extended-spectrum beta-lactamase in a Shigella sonnei clinical isolate Scand J Infect Dis 35 2003 503 505
84. W. Basualdo, A. Arbo Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children Pediatr Infect Dis J 22 2003 374 377